Performance
Trailing returns
| 1 day | +0.35% |
| |||
| 1 week | +1.22% |
| |||
| 4 week | +7.49% |
| |||
| 3 month | +9.11% |
| |||
| YTD | +11.95% |
| |||
| 1 year | +30.81% |
| |||
| 3 years* | +11.25% |
| |||
| 5 years* |
| -2.69% | |||
| *annualized | |||||
| Best 3 month return | +36.02% | |
| Worst 3 month return | -34.15% |
Morningstar statistics
Morningstar category: Foreign Large Value
| Return | Risk | Rating | |
| 3 years | Average | Below Average |
 
|
| 5 years | Below Average | Below Average |
|
| 10 years | - | - | - |
| Overall | Below Average | Below Average |
|
Morningstar style Learn more
| Large | |||
| Mid | |||
| Small | |||
| Value | Blend | Growth |
Key statistics
| Total assets | 498.10M | |
| Front load | - | |
| Deferred load | 1.00% | |
| Expense ratio | 2.40% | |
| Management fee | - | |
| Fund family | Delaware Investments |
Asset allocation
| Cash | 2.29% | |
| Stocks | 97.60% | |
| Bonds | 0.00% | |
| Other | 0.11% |
Purchase information
| Initial | US$2,500 | |
| Additional | US$100 | |
| IRA Initial | US$250 |
11.39-0.17(-1.47%)
May 23, 4:00PM EDT
Overall Morningstar RatingTM
Description
The investment seeks long-term growth of capital and may also seek income. The fund invests primarily in non-U.S. securities, including securities of issuers located in emerging markets, but, in any event, will invest at least 65% of its net assets in non-U.S. securities. It intends to invest primarily in common stocks, but it may also invest in other securities that the sub-advisers believe provide opportunities for capital growth and income, such as preferred stocks, warrants, and securities convertible into common stocks.
Fund filings (PDF) »
Fund filings (PDF) »
Asset managers:
Ian Jamieson (Started: Mar 9, 2012)
Melissa Platt (Started: Apr 29, 2011)
Nigel Hart (Started: Jun 30, 2012)
Nigel May (Started: Apr 29, 2011)
Thomas Callan (Started: Dec 19, 2008)
Ian Jamieson (Started: Mar 9, 2012)
Melissa Platt (Started: Apr 29, 2011)
Nigel Hart (Started: Jun 30, 2012)
Nigel May (Started: Apr 29, 2011)
Thomas Callan (Started: Dec 19, 2008)
Delaware Investments, 2005 Market Street, One Commerce Square, Philadelphia, PA 19103, USA
215-255-1196 (Fax)
Risk
| 1 year | 3 years | 5 years | 10 years | ||
| Alpha* | -2.29 | -1.51 | -1.99 | - | |
| Beta* | 0.91 | 0.93 | 0.97 | - | |
| Mean annual return | 1.26 | 0.58 | -0.02 | - | |
| R-squared* | 97.32 | 97.98 | 97.55 | - | |
| Standard deviation | 14.93 | 18.28 | 22.73 | - | |
| Sharpe ratio | 1.00 | 0.37 | -0.02 | - | |
| * Against standard index | |||||
Top 10 holdings
| Security | Net Assets | |
| Sanofi (SAN) | 2.64% | |
| Novartis AG (NVSEF) | 2.62% | |
| Roche Holding AG (RHHVF) | 2.26% | |
| Eni SpA (ENI) | 1.93% | |
| Toyota Motor Corp (7203) | 1.69% | |
| Unilever PLC (UNLYF) | 1.62% | |
| Canon, Inc. (CAJFF) | 1.43% | |
| BG Group PLC (BG.) | 1.38% | |
| Tesco PLC (TSCO) | 1.36% | |
| GlaxoSmithKline PLC (GLAXF) | 1.28% |